Log in


canadian entrepreneurs

in life science


Become a CELS Member Today!

Most CELS events including VR Webinars include a coupon code for free individual and Start-Up (Bundled Individual) memberships, that can be used here. Join CELS now to start exploring your instant Life Science network!

Investors and Startups in Down Markets: Dealing with Today’s Market Turmoil

  • September 28, 2022
  • 12:00 PM - 1:00 PM
  • Webinar

Registration

  • Public Access Webinar for the Global Life Sciences Community

Registration is closed



Public markets have seen major declines this year as the twelve year bull market shudders to a close. 

Angel Capital Association (ACA) Vice Chair Ron Weissman will describe the likely impact of our troubled equity markets on angel investors and their portfolio companies. Addressing some of the following questions:

What happened in the first half of 2022?

Where are we now? What happens to startups in down markets?

How can angels protect themselves and their portfolio companies?

What’s in store for valuation? Diligence? Deal terms?

Further, Ron will discuss smart practices in dealing with the current economy where markdowns in public markets lead to changed economics across the capital spectrum. 

WEBINAR DETAILS

Date: Wednesday, September 28, 2022

Time: 12:00 pm - 1:00 pm (Pacific Time)

Join Info: Dial-in & Web Access Information Provided with Registration Confirmation Email

SPEAKER


Ron Weisman

Vice Chair, Angel Capital Association and      Chair, Software Group, Band of Angels

LinkedIn

Ron is Vice Chair of the Angel Capital Association (ACA), North America’s principal organization for professional angel investors.

Also, he is Chair of the ACA’s education committee and is the author of the ACA’s official courses on Early-Stage Boards of Directors and of Managing and Mitigating Angel Investor Risks.

Ron is also Chair of the Software Interest Group at the Band of Angels, Silicon Valley’s oldest angel group. He has been an active member for the past sixteen years. He invests in AI, analytics, business software and health IT systems. He spent seventeen years as a partner at Apax Partners, a global VC/PE firm where he focused on technology investing and cross border investing across Apax’s investment teams in the US, Europe, the UK and Israel.

Between his overlapping VC and angel careers, he has invested in or advised more than seventy startups and has served on more than forty boards. Recent exits have included Taulia (invoice arbitrage, sold to SAP in 2022—sale pending) and Gainsight (customer experience management, sold to Vista Equity Partners in 2021).

Currently, he is also an advisor to Neva SGR, the venture capital arm of Italy’s largest banking conglomerate, Intesa Sanpaolo.

He has spent the past decade teaching angel best practices to angels and regional and national governments in startup hubs around the world, including Australia, Armenia, Chile, Georgia, Germany, Israel, Italy, Japan, New Zealand and Ukraine.

He writes and speaks frequently about venture and angel investing, AI investing trends, capital models, and startup hub best practices as well as lessons the COVID generation can learn from the Black Death’s impact on European society.

Prior to becoming an early-stage investor, he was Chief Marketing Officer and head of Investor Relations for Verity, the market leader in corporate information retrieval. During his tenure the  company won Large Cap Turnaround of the Year. Earlier, he was a direct report to Steve Jobs at NeXT, where he managed global marketing strategy and European marketing. Prior to NeXT he spent twelve years working for civilian and other federal agencies, concurrent with professorships and university computing roles at the University of Maryland and Brown University.

He received his BA, MA and Ph.D. degrees from the University of California, Berkeley and is a former Fulbright Scholar (Italy).

info@cels-sfo.com

© 2022 Canadian Entrepreneurs in Life Science. All Rights Reserved.